ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.99
0.42%
US Tech 100
20,389.60
0.88%
S&P 500
6,032.38
0.56%
US Dollar vs CAD
1.40155
-0.01%
Bitcoin
96,280.48
-1.25%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Moderna Inc (MRNA)

  7. Moderna Inc (MRNA) News

MRNA

Moderna (MRNA)

Moderna Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRNA
DateTimeSourceHeadlineSymbolCompany
11/29/20242:54PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
11/29/20242:49PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
11/29/20242:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
11/12/20243:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
11/12/20248:27AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
11/08/20246:30AMPR Newswire (US)Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular CarcinomaNASDAQ:MRNAModerna Inc
11/07/20243:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNAModerna Inc
11/07/20245:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNAModerna Inc
11/07/20245:19AMIH Market NewsU.S. Futures Rise as Investors Await Fed Rate Decision; Oil Prices DropNASDAQ:MRNAModerna Inc
11/06/20245:09AMIH Market NewsTrump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%; Coinbase Rises with BTC All-Time HighNASDAQ:MRNAModerna Inc
11/05/20248:05AMPR Newswire (US)Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024NASDAQ:MRNAModerna Inc
10/28/20245:45AMBusiness WireMerck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)NASDAQ:MRNAModerna Inc
10/23/20247:00AMPR Newswire (US)Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering IntelligenceNASDAQ:MRNAModerna Inc
10/08/20243:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
10/07/20244:45AMPR Newswire (US)Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNANASDAQ:MRNAModerna Inc
10/04/20247:52AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
10/04/20247:49AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
10/03/20247:00AMPR Newswire (US)Invaio Sciences Appoints André Andonian as Chairman of the Board of DirectorsNASDAQ:MRNAModerna Inc
10/02/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNAModerna Inc
09/30/20244:45AMPR Newswire (US)MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:MRNAModerna Inc
09/26/20244:45AMPR Newswire (US)Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:MRNAModerna Inc
09/23/20244:45AMPR Newswire (US)Moderna, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNANASDAQ:MRNAModerna Inc
09/19/20244:45AMPR Newswire (US)The Gross Law Firm Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNANASDAQ:MRNAModerna Inc
09/16/20244:45AMPR Newswire (US)MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:MRNAModerna Inc
09/13/20245:12AMIH Market NewsOpenAI Unveils Strawberry AI Model Series; Boeing Stock Falls 4% Amid Strike; HR Surges 20% on Growth ForecastNASDAQ:MRNAModerna Inc
09/12/20245:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNAModerna Inc
09/12/20244:45AMPR Newswire (US)Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNANASDAQ:MRNAModerna Inc
09/10/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
09/10/20246:30AMPR Newswire (US)Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune DiseasesNASDAQ:MRNAModerna Inc
09/09/20242:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
 Showing the most relevant articles for your search:NASDAQ:MRNA

Your Recent History

USOTC
WDLF
Decentral Life (PK)
AMEX
KULR
KULR Technology
USOTC
IQST
iQSTEL (QX)
USOTC
RNVA
Rennova Health (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
QSEP
QS Energy (PK)
USOTC
ERHE
ERHC Energy (CE)
NYSE
IONQ
IonQ
NASDAQ
SMCI
Super Micro Computer
USOTC
BIEL
Bioelectronics (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
FCEL
FuelCell Energy
COIN
XRPUSD
Ripple
USOTC
ASII
Accredited Solutions (PK)
USOTC
HIRU
Hiru (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1305.00 only $522.00